Highlights

  • First Graphene reported approximately AUD 201,000 of combined income in the September quarter, up 21% year on year.
  • Pacific Urethanes placed an initial production order for a Mining application following development work using PureGRAPH graphene.
  • A three-year UNITEX agreement announced on 16 November targets graphene-enhanced composites, with further commercialisation dependent on successful development and terms.
  • Commercialisation remains dependent on customer purchase orders, successful trials and the conversion of development programs into ongoing sales.

First Graphene Limited (ASX:FGR) supplies PureGRAPH graphene products for materials including concrete, polymers and composites. On 16 November 2026, it announced a three-year development agreement with China’s UNITEX Composite. Shares traded at AUD 0.035, up 2.94%, on 17 November, while the Partnership added another route for evaluating and commercialising graphene-enhanced materials.

Income Includes Sales And Research Programs

The report, dated 20 October, recorded approximately AUD 201,000 in unaudited combined income for Q1 FY27, a 21% increase on Q1 FY26. That total comprised approximately AUD 100,000 in graphene and product development sales and AUD 101,000 from collaborative projects and research programs.

The components are distinct: combined income includes development and research contributions as well as product-related sales. New client orders contributed to the quarterly improvement as the company widened its range of applications and customer engagements.

The company’s presence in the United States included an investor roadshow and participation in the CAMX trade show. These activities supported customer engagement, although prospective opportunities remain separate from contracted sales.

UNITEX Agreement Targets Composites Development

UNITEX Composite, part of UNITEX Group, brings materials engineering and Manufacturing capabilities in China. The agreement combines those capabilities with First Graphene’s formulation and dispersion expertise.

Initial work targets graphene-enhanced carbon fibre prepreg. Successful formulations may advance through customer validation, manufacturing scale-up and commercialisation, subject to agreement on applicable commercial terms. Other potential applications include thermoplastics, resin concentrates, coatings and elastomers.

The agreement runs for three years and either party may cancel with three months’ notice. It establishes a development pathway rather than guaranteed orders or a disclosed Recurring Revenue commitment.

November Orders Add Commercial Evidence

On 10 November, First Graphene reported an approximately AUD 35,000 repeat order from an established US customer supplying conductive inks for defence applications. Two initial graphene oxide orders brought the combined value to approximately AUD 45,000.

The graphene oxide orders relate to consumer electronics and construction materials. Their size provides a measure of current activity, separate from the broader markets the company is targeting.

Earlier work included Pacific Urethanes’ first production order for mining fire-retardancy applications and a three-year Aeropreg development agreement for carbon fibre prepreg. These programs cover different stages of testing, validation and commercial manufacture.

Order Conversion Shapes The Next Stage

In cement and concrete, First Graphene disclosed a memorandum of understanding with The Sixth Element to distribute PureGRAPH CEM in China. Its Breedon relationship also continued through a twelve-month extension of an exclusive commercialisation agreement.

The disclosed activities span signed development partnerships, initial production orders and negotiations. Their different stages remain relevant when assessing progress: research results and customer discussions do not carry the same commercial certainty as completed purchases.

At the time of writing, Market Capitalisation was AUD 31.07 million. The shares remained down 56.25% over one year. Execution priorities include validating new applications and converting customer interest into commercial orders while supporting ongoing development expenditure.